Claims
- 1. A compound selected from those of the formula ##STR27## and the pharmaceutically acceptable acid addition salts thereof, wherein R.sub.1 and R.sub.2 are each selected from the group consisting of normal alkyl of from 12 to 20 carbon atoms and normal alkenyl not having a double bond in the 1-position of from 12 to 20 carbon atoms.
- 2. A compound of claim 1 wherein R.sub.1 and R.sub.2 are each normal alkyl of from 14 to 18 carbon atoms.
- 3. A compound of claim 2 wherein R.sub.1 and R.sub.2 each contain the same number of carbon atoms.
- 4. The compound of claim 1 wherein R.sub.1 and R.sub.2 are each n-tetradecyl.
- 5. The compound of claim 1 wherein R.sub.1 and R.sub.2 are each n-hexadecyl.
- 6. The compound of claim 1 wherein R.sub.1 and R.sub.2 are each n-octadecyl.
- 7. A pharmaceutical composition containing an antivirally effective amount of a compound of claim 1 as the essential active ingredient in a pharmaceutically acceptable carrier.
- 8. A method of prophylactically controlling a viral infection in a mammal which comprises administering an amount effective to prophylactically control said viral infection of a compound of claim 1.
- 9. A method of inducing the production of interferon in a mammal which comprises administering an amount effective to induce the production of interferon of a compound of claim 1.
CROSS-REFERENCE TO RELATED APPLICATION
This application is a division of application Ser. No. 825,535 filed Aug. 18, 1977.
Divisions (1)
|
Number |
Date |
Country |
Parent |
825535 |
Aug 1977 |
|